What This Means for Women in Midlife If you're considering a GLP-1 medication for weight management, the question isn't just "which medication?" it's "what else is going on hormonally?" For women in perimenopause or postmenopause, addressing estrogen deficiency may: Enhance the weight loss response to GLP-1 medications [1] Improve the metabolic benefits including better insulin sensitivity and reduced visceral fat [7, 8] Address symptoms like sleep disruption, hot flashes, and mood changes that can undermine weight loss efforts [10] Support long-term cardiovascular health during a period of accelerated risk [9] This is why a comprehensive approach one that evaluates both your metabolic health and your hormonal status matters so much more than choosing a single medication in isolation
An initial consultation will allow the provider to decide if you are a candidate for semaglutide drops
It has also affected economics, especially in developed countries
How Tirzepatide Fits Into the Equation Tirzepatide is a dual GIP/GLP-1 receptor agonist, and it has taken the metabolic health world by storm due to its impressive weight loss results
Next Step: Take our free assessment quiz to see if a personalized GLP-1 program is the right fit for your weight loss goals
The 28-day countdown begins the moment the vials stopper is first punctured, regardless of how many times you access it afterward
,aspect=ignore)
